Governance Novartis AG

NOVN

CH0012005267

Prodotti farmaceutici

Mercato chiuso - Swiss Exchange Altri mercati azionari 17:30:30 08/05/2026			Variaz. 5gg	Var. 1 gen.
113,36 ^CHF	+0,05%		-2,19%	+3,43%

07/05	Novartis avvia la costruzione di un impianto di terapie oncologiche in Texas	MT
07/05	Novartis AG - Il sito di Denton dovrebbe diventare operativo nel 2028 e creare nuovi posti di lavoro negli Stati Uniti	RE

Comitato esecutivo: Novartis AG

Manager

Posizioni ricoperteDa

Vasant Narasimhan

50 anni

Chief Executive Officer

01/02/2018

Charlotte Pamer-Wieser

52 anni

Corporate Secretary

01/09/2011

Mukul Mehta

Director of Finance/CFO

16/03/2026

Teresa Jose

58 anni

Comptroller/Controller/Auditor

01/07/2025

Maria Victoria Cuevas-Pautonnier

Investor Relations Contact

01/01/2022

Shreeram Aradhye

64 anni

Chief Tech/Sci/R&D Officer

16/05/2022

Robert Kowalski

58 anni

Human Resources Officer

01/09/2021

Karen Hale

58 anni

Compliance Officer	14/04/2025
General Counsel	15/05/2021

Steffen Lang

59 anni

Chief Operating Officer

04/04/2022

Composizione del Consiglio di amministrazione: Novartis AG

Amministratore

ComitatiDa

Giovanni Caforio

61 anni

Governance Committee
Nominating Committee
Compensation Committee Chair
HR Committee Chair

Bridgette Heller

65 anni

Compensation Committee Chair	13/09/2019
Audit Committee	28/02/2020
Compensation Committee	28/02/2020
Governance Committee	02/02/2021
Nominating Committee	02/02/2021
Finance Committee

Frans van Houten

66 anni

Audit Committee
Governance Committee	07/03/2025
Nominating Committee	07/03/2025
Governance Committee Chair
Nominating Committee Chair

Patrice Bula

70 anni

Compensation Committee	28/02/2019
Governance Committee Chair	28/02/2019
Nominating Committee Chair	28/02/2019

Simon Moroney

67 anni

Compensation Committee Chair	28/02/2020
Compensation Committee	01/04/2021
Nominating Committee	01/04/2021

Ana de Pro Gonzalo

59 anni

Audit Committee	04/03/2022
Compensation Committee	04/12/2021
Audit Committee Chair	01/06/2020

Nancy Andrews

68 anni

Governance Committee Chair	20/05/2025
Nominating Committee Chair	20/05/2025
Compensation Committee	01/02/2021

John Young

62 anni

Compensation Committee Chair
Governance Committee
Compensation Committee	07/03/2025

Liz Doherty Doherty

69 anni

Audit Committee Chair

10/05/2019

Ton Büchner

61 anni

Audit Committee

02/03/2018

Elizabeth McNally

65 anni

Director/Board Member	07/03/2025
Independent Dir/Board Member	07/03/2025

Charles Swanton

54 anni

Director/Board Member

06/03/2026

Ultime nomine: Novartis AG

04/05	Kyverna Therapeutics, Inc. nomina Nadia Dac Chief Commercial Officer con decorrenza dal 4 maggio 2026	CI
29/04	Olema Pharmaceuticals, Inc. nomina il Dott. Prakash Raman nel Consiglio di Amministrazione	CI
22/04	Novabridge Biosciences nomina Mark Hagler Presidente e Chief Commercial Officer	CI
20/04	Neurogene Inc. annuncia nuove nomine nel management e nel Consiglio di Amministrazione	CI
20/04	Neurogene, Inc. annuncia cambiamenti ai vertici e nel Consiglio di Amministrazione	CI
16/04	Aktis Oncology, Inc. annuncia cambiamenti nel Consiglio di Amministrazione	CI
15/04	Tango Therapeutics, Inc. annuncia nuove nomine ai vertici aziendali	CI

Altre notizie

Ex dirigenti e amministratori: Novartis AG

Insider

Posizioni ricoperte

DaA

Srikant T. Madhav Datar

Director/Board Member	01/01/2003	01/01/2021
Independent Dir/Board Member	01/01/2003	01/01/2021

Pierre Landolt

Director/Board Member	08/01/2010	02/03/2018
Independent Dir/Board Member	08/01/2010	02/03/2018
Corporate Officer/Principal	01/01/1996	08/01/2010

Joseph Jimenez

Director/Board Member	02/11/2009	08/01/2010
Chief Executive Officer	01/02/2010	01/01/2018
Corporate Officer/Principal	08/01/2010	26/01/2010

Jürgen Brokatzky-Geiger

Human Resources Officer	01/01/2005	06/03/2014
Corporate Officer/Principal	06/03/2014	01/10/2017

Wendelin Wiedeking

Director/Board Member	01/01/2003	25/02/2014
Independent Dir/Board Member	01/01/2003	25/02/2014
Corporate Officer/Principal	01/01/2003	08/01/2010

Rolf M. Zinkernagel

Director/Board Member	08/01/2010	25/02/2014
Independent Dir/Board Member	01/01/1999	25/02/2014
Corporate Officer/Principal	01/01/1999	08/01/2010

Alexandre F. Jetzer-Chung

Director/Board Member	08/01/2010	22/02/2011
Corporate Officer/Principal	01/01/1996	08/01/2010

Raymund Breu

Director of Finance/CFO

01/12/1996

01/01/2009

Hans Jörg Reinhardt

Chief Operating Officer	01/01/2008	01/01/2010
Corporate Officer/Principal	01/01/2006	01/01/2008
Chairman	01/01/2013	07/03/2025
Independent Dir/Board Member	01/01/2013	07/03/2025

William Brody

Director/Board Member	24/02/2009	-
Independent Dir/Board Member	25/08/2011	-

Urs Bärlocher

General Counsel

01/01/1999

31/08/2007

Thomas Ebeling

Corporate Officer/Principal

01/01/2000

01/01/2007

Karen Hübscher

Public Communications Contact

01/01/2000

01/01/2006

Andreas von Planta

Director/Board Member	01/01/2006	-
Independent Dir/Board Member	01/01/2006	-

Pierre F. Dodion

Sales & Marketing

01/01/2002

01/01/2006

François Martelet

Corporate Officer/Principal

01/07/2003

01/07/2005

Ian Garland

Corporate Officer/Principal

01/06/2005

Joachim P. H. Schupp

Corporate Officer/Principal

01/01/1985

01/10/2004

Ronen Tamir

Investor Relations Contact	28/10/2011	-
Public Communications Contact	28/10/2011	-
Corporate Officer/Principal	01/01/2004	28/10/2011

Marshall E. Reese

Corporate Officer/Principal

01/01/1999

01/01/2004

Mihael Polymeropoulos

Corporate Officer/Principal

01/01/1998

01/01/2003

Gilbert Wenzel

Corporate Officer/Principal

01/11/2000

01/01/2003

Paul Herrling

Chief Tech/Sci/R&D Officer

01/11/2002

Bruce F. Fleming

Corporate Officer/Principal

01/06/2001

01/06/2002

Silke Zentner

Public Communications Contact

05/04/2002

Fredrik Ollila

Corporate Officer/Principal

01/01/2002

Paolo Baroldi

Corporate Officer/Principal

01/01/1998

01/01/2002

James New

Corporate Officer/Principal

01/01/1999

Helmut Sihler

Director/Board Member

01/01/1996

Birgit Breuel

Corporate Officer/Principal

01/01/1996

Norman Hardman

Chief Tech/Sci/R&D Officer

01/01/1996

Peter Burckhardt

Director/Board Member	31/12/2009	-
Corporate Officer/Principal	01/01/1996	31/12/2009

John McKenna

Corporate Officer/Principal

01/01/1990

Ann Bailey

Public Communications Contact

01/01/1982

Gabor Veres

Corporate Officer/Principal

Siv Lindbratt Börjes

Corporate Officer/Principal

Adrian Hunter

Corporate Officer/Principal

MaryAnn DeMarco

Corporate Officer/Principal

David Metzger

Corporate Officer/Principal

Virginia Jamieson

Corporate Officer/Principal

Max Burger

Chairman	21/04/2010	-
President	17/07/2009	21/04/2010

Ian Stuart Charles Talmage

Corporate Officer/Principal

Michael Horne

Corporate Officer/Principal

John McAdoo

Corporate Officer/Principal

Ian Matthews

Corporate Officer/Principal

Geoff MacKay

Corporate Officer/Principal

Jutta Monika Heim

Corporate Officer/Principal

Peter Thomas Sany

Chief Tech/Sci/R&D Officer

William P. Keane

Corporate Officer/Principal

Nagesh Mahanthappa

Corporate Officer/Principal

Ann Moravick

Corporate Officer/Principal

Bobby Singh

Corporate Officer/Principal

Dominique Cheneval

Corporate Officer/Principal

John H. van Duzer

Corporate Officer/Principal

Randall S. Moore

Corporate Officer/Principal

Eric Wayne Evans

Director of Finance/CFO

Christoph Hüls

Corporate Officer/Principal

Ingrid Duplain

Corporate Secretary

Bruno Heynen

Corporate Secretary

Corinne Hoff

Public Communications Contact

Stuart J. Davie

Chief Tech/Sci/R&D Officer

Günter Frankenne

Director/Board Member

Karel Petrak

Corporate Officer/Principal

Peter E. Carlin

Corporate Officer/Principal

Terry Hart

Corporate Officer/Principal

Geert C. Mudde

Corporate Officer/Principal

Phil Johnson

Corporate Officer/Principal

Malcolm B. Cheetham

Comptroller/Controller/Auditor

James Phillips

Corporate Officer/Principal

Maike July-Grolman

Corporate Officer/Principal

Armin M. Kessler

Sales & Marketing

Hans-Georg Capraro

Corporate Officer/Principal

William J. Rutter

Director/Board Member

Gordon Wright

Corporate Officer/Principal

Jeret Bode

Corporate Officer/Principal

Rob Goshert

Corporate Officer/Principal

Jeffrey Hrkach

Corporate Officer/Principal

Peter Herold

Corporate Officer/Principal

Thomas Littke

Corporate Officer/Principal

John Slevin

Corporate Officer/Principal

Cees Winnips

Corporate Officer/Principal

Humphrey Harte

Corporate Officer/Principal

Distribuzione dell'età dei dirigenti

Parità di genere

Uomo	21
Donna	9

Di cui Comitato esecutivo

Uomo	6
Donna	3

Di cui Direttori

Uomo	9
Donna	3

Revisioni

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Novartis AG è uno dei leader mondiali nella progettazione, produzione e commercializzazione di prodotti farmaceutici. Le vendite nette sono ripartite per area terapeutica come segue: - oncologia (30,9%); - immunologia (18,9%); - malattie cardiovascolari, renali e metaboliche (16,4%); - neuroscienze (11%). Il restante fatturato netto (22,8%) proviene dalla produzione conto terzi di prodotti farmaceutici. Alla fine del 2025, Novartis AG contava oltre 31 siti produttivi in tutto il mondo. Il fatturato netto è distribuito geograficamente come segue: Svizzera (2,6%), Europa (28,1%), Stati Uniti (42,8%), Asia/Africa/Australasia (19,8%), Canada e America Latina (6,7%).

Dipendenti

75.267

Settore

Prodotti farmaceutici

Calendario

Pubblicazioni dei risultati - Q2 2026

Altre informazioni sulla società